Complement Mutation-AssociatedDe NovoThrombotic Microangiopathy Following Kidney Transplantation
about
Atypical hemolytic uremic syndromeRelative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotypeA clinicopathologic study of thrombotic microangiopathy in IgA nephropathyEculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.STEC-HUS, atypical HUS and TTP are all diseases of complement activation.Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients.Atypical HUS associated with severe, unexpected antibody-mediated rejection post kidney transplant.A 'silent', new polymorphism of factor H and apparent de novo atypical haemolytic uraemic syndrome after kidney transplantationAtypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literatureAn international consensus approach to the management of atypical hemolytic uremic syndrome in children.Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.Differing tales of two patients after receiving a kidney transplant from a donor with disseminated intravascular coagulationRare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levelsComplement factor I deficiency: a not so rare immune defect: characterization of new mutations and the first large gene deletionCharacteristics and Outcomes of Renal Transplant Recipients with Hemolytic Uremic Syndrome in the United States.The Genetics of Ultra-Rare Renal Disease.Prevalence in the General Population of a CFH Sequence Variant Associated with Atypical Haemolytic Uraemic Syndrome in an Extensive Family from Southwest England.Thrombotic microangiopathy in renal allografts.Routine use of clinical exome-based next-generation sequencing for evaluation of patients with thrombotic microangiopathies.Early Versus Late Diagnosis of Complement Factor I Deficiency: Clinical Consequences Illustrated in Two Families with Novel Homozygous CFI Mutations.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Factors influencing treatment of atypical hemolytic uremic syndrome.Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies.Safety and effectiveness of restrictive eculizumab treatment in atypical haemolytic uremic syndrome.Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.Belgian consensus statement on the diagnosis and management of patients with atypical hemolytic uremic syndrome.Transplant glomerulopathy.Thrombotic Microangiopathy and the Kidney.Antibody mediated rejection associated with complement factor h-related protein 3/1 deficiency successfully treated with eculizumab.Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation.Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease.Eculizumab for the treatment of atypical hemolytic uremic syndrome recurrence after kidney transplantation associated with complement factor H mutations: a case report with a 5-year follow-up.De Novo Atypical Haemolytic Uremic Syndrome after Kidney Transplantation.Atypical hemolytic uremic syndromeManagement of hemolytic uremic syndromeComplement-mediated renal diseases after kidney transplantation - current diagnostic and therapeutic options in and recurrent diseases
P2860
Q21202864-C41C8A94-7DDF-42F1-97B4-0E00906156CEQ24613907-7DB555B3-A8A4-48ED-93DA-F3625DA8D79DQ33397974-47AC7C78-6764-41B8-B3F5-CA854872D3EDQ33403196-48215EBF-D8EE-4D45-947B-8F4E94B37A22Q33403359-8CA1B874-7167-40D7-879E-99F3B5D0EA99Q33403607-5A35F2DA-75AF-4D1A-A0C4-DD715A418170Q33405522-7E736944-D9E4-4056-B0D6-7D4B4463EB76Q33409586-A843D975-E3A6-462C-A5C0-56ECFA318C9FQ33412869-FE2F34F1-4FEC-4112-942B-2C5352246468Q33419481-09764309-7C40-40D8-8F2E-D4C7BE4B1E16Q33419812-D49FFE88-04F3-40E7-BDF3-7406B2989E92Q33421861-B9840EA0-2D79-407C-8C8C-4D588CFCC937Q33424946-53435187-487E-4D12-B814-3E90337C4D5DQ33430681-BA916FAC-87FC-4021-AAB6-68C2B12F7DB6Q33430817-5524E0BB-9809-4622-8157-412D96FE6383Q33908301-AE435EDA-1161-439A-9643-AB061B586B84Q35693886-857E16C1-07DA-409B-A2C3-FB40D9D51A66Q36281655-F96A33CD-E9EA-405D-A22C-B8091196471EQ36641955-C8A38851-D818-4D41-A16B-E819BD9235ACQ37032691-62B5C867-7902-4718-AC7B-7D2780FF6280Q37251362-4B1B35BF-B57C-4965-AE58-B73A84D5D5FFQ37589777-DB342BF1-08D4-45A0-9E16-D6766D3E2BAFQ38655720-32A4FB7E-7741-4DF6-8D7C-C93533172765Q41994752-4D86A1C4-2653-4098-A18F-87DA5B0C3648Q42086661-6FEE07A9-53DE-4F83-AD62-2C78707FF44AQ42858176-8DB13B65-8E74-48B8-BF02-C4640CF3279BQ47096270-6514A5AF-9E42-4475-933C-6764C75104A6Q47225732-6F3D8886-44F4-40D2-B4F9-AF99966D20D1Q47251151-422C2F92-F164-4A20-9CBB-E79B2AF80579Q48146844-64016646-CD17-4EA5-8E25-71153F42E70AQ50063069-62927066-1909-4CDB-B98A-67A8A160086EQ50085453-4FA59CAA-B0F0-4D51-99C2-704D374E6149Q51333222-0305C6B8-7B6D-4045-A213-CB5B66FBBF1CQ51353137-9863ACDC-69D5-4396-89FB-0D6AEF4D99D8Q51754901-E681B7C7-7ECB-4370-AE71-7E2013E9F0B6Q53180638-86122950-49CE-4F8F-8CF5-CA5FAFF48868Q55128066-99F4E703-C964-4246-B7FB-A382BAC74665Q56591965-91F7AA77-7C54-4286-9603-04E6418C482BQ57161996-E000648D-5002-4CDB-9439-7C43BB1A8682Q58120548-44AC9546-09A2-4626-922D-F1EFE88FD20C
P2860
Complement Mutation-AssociatedDe NovoThrombotic Microangiopathy Following Kidney Transplantation
description
im Juni 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 28 June 2008
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2008
@uk
name
Complement Mutation-Associated ...... llowing Kidney Transplantation
@en
Complement Mutation-Associated ...... llowing Kidney Transplantation
@nl
type
label
Complement Mutation-Associated ...... llowing Kidney Transplantation
@en
Complement Mutation-Associated ...... llowing Kidney Transplantation
@nl
prefLabel
Complement Mutation-Associated ...... llowing Kidney Transplantation
@en
Complement Mutation-Associated ...... llowing Kidney Transplantation
@nl
P2093
P50
P1476
Complement mutation-associated ...... llowing kidney transplantation
@en
P2093
C Legendre
F Fakhouri
V Frémeaux-Bacchi
P304
P356
10.1111/J.1600-6143.2008.02297.X
P407
P577
2008-06-28T00:00:00Z